Truist Financial Corp Edwards Lifesciences Corp Transaction History

Truist Financial Corp

$65 Billion
Q2 2024

A detailed history of Truist Financial Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Truist Financial Corp holds 70,395 shares of EW stock, worth $4.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

70,395

Previous 76,950 8.52%

Holding current value

$4.61 Million

Previous $7.35 Million 11.57%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 20, 2024	SELL	$84.3 - $94.31 $552,586 - $618,202	-6,555 Reduced 8.52%	70,395 $6.5 Million
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $1.12 Million - $1.47 Million	-15,413 Reduced 16.69%	76,950 $7.35 Million
Q4 2023 Feb 02, 2024	SELL	$61.71 - $77.76 $3.07 Million - $3.87 Million	-49,788 Reduced 35.02%	92,363 $7.04 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $3.32 Million - $4.48 Million	47,975 Added 50.94%	142,151 $9.85 Million
Q2 2023 Aug 01, 2023	BUY	$81.41 - $94.33 $126,511 - $146,588	1,554 Added 1.68%	94,176 $8.88 Million
Q1 2023 May 05, 2023	BUY	$74.26 - $84.51 $249,142 - $283,531	3,355 Added 3.76%	92,622 $7.66 Million
Q4 2022 Feb 17, 2023	SELL	$68.3 - $87.44 $737,503 - $944,177	-10,798 Reduced 10.79%	89,267 $6.66 Million
Q3 2022 Oct 26, 2022	SELL	$82.37 - $107.29 $419,922 - $546,964	-5,098 Reduced 4.85%	100,065 $8.27 Million
Q2 2022 Jul 22, 2022	SELL	$86.5 - $128.27 $1.24 Million - $1.83 Million	-14,286 Reduced 11.96%	105,163 $10 Million
Q1 2022 Apr 22, 2022	BUY	$101.96 - $128.34 $862,173 - $1.09 Million	8,456 Added 7.62%	119,449 $14.1 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $610,138 - $749,580	-5,736 Reduced 4.91%	110,993 $14.4 Million
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $782,116 - $932,900	7,600 Added 6.96%	116,729 $13.2 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $235,925 - $294,794	-2,814 Reduced 2.51%	109,129 $11.3 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $381,519 - $439,658	4,849 Added 4.53%	111,943 $9.36 Million
Q4 2020 Feb 18, 2021	BUY	$71.69 - $91.23 $368,486 - $468,922	5,140 Added 5.04%	107,094 $9.77 Million
Q3 2020 Nov 05, 2021	BUY	$67.19 - $87.44 $8,465 - $11,017	126 Added 0.12%	101,954 $8.14 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $1.03 Million - $1.34 Million	15,322 Added 17.71%	101,828 $8.13 Million
Q2 2020 Nov 16, 2021	BUY	$57.54 - $76.95 $7,250 - $9,695	126 Added 0.15%	86,506 $5.98 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $3.37 Million - $4.51 Million	58,547 Added 210.35%	86,380 $5.97 Million
Q1 2020 Nov 05, 2021	BUY	$52.41 - $81.0 $2,201 - $3,402	42 Added 0.15%	27,833 $5.25 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $275,624 - $425,979	-5,259 Reduced 15.91%	27,791 $5.24 Million
Q4 2019 Nov 16, 2021	BUY	$71.7 - $82.09 $3,011 - $3,447	42 Added 0.13%	33,050 $7.71 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $2.16 Million - $2.47 Million	30,095 Added 1033.13%	33,008 $7.7 Million
Q3 2019 Oct 31, 2019	SELL	$61.55 - $75.43 $28,928 - $35,452	-470 Reduced 13.89%	2,913 $640,000
Q2 2019 Jul 24, 2019	BUY	$55.74 - $64.41 $26,755 - $30,916	480 Added 16.53%	3,383 $625,000
Q1 2019 Apr 23, 2019	BUY	$47.89 - $64.05 $3,017 - $4,035	63 Added 2.22%	2,903 $556,000
Q4 2018 Jan 22, 2019	SELL	$46.41 - $56.94 $6,822 - $8,370	-147 Reduced 4.92%	2,840 $435,000
Q3 2018 Oct 17, 2018	SELL	$45.7 - $58.03 $44,191 - $56,115	-967 Reduced 24.46%	2,987 $520,000
Q2 2018 Jul 26, 2018	BUY	$42.45 - $51.3 $31,625 - $38,218	745 Added 23.22%	3,954 $576,000
Q1 2018 Apr 20, 2018	SELL	$37.19 - $47.45 $50,169 - $64,010	-1,349 Reduced 29.6%	3,209 $448,000
Q4 2017 Jan 29, 2018	SELL	$33.79 - $39.39 $88,191 - $102,807	-2,610 Reduced 36.41%	4,558 $514,000
Q3 2017 Oct 23, 2017	BUY	$36.29 - $38.83 $260,126 - $278,333	7,168	7,168 $784,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Edwards Lifesciences Corp Transaction History